Taken together, these observations indicate that FSP1 and GPX4 cooperatively establish a dual-layer antioxidant defense system in PDAC cells, enabling KRAS-mutated tumor cells to bypass the “ferroptosis checkpoint” and facilitating their survival and proliferation [27,62,63]. The gene discussed is AIFM2; the disease is neoplasm.